Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-74.82%
operating margin TTM
-97.23%
revenue TTM
31.42 Million
revenue per share TTM
0.36$
valuation ratios | |
|---|---|
| pe ratio | -20.00 |
| peg ratio | -0.39 |
| price to book ratio | 2.94 |
| price to sales ratio | 14.63 |
| enterprise value multiple | -21.79 |
| price fair value | 2.94 |
profitability ratios | |
|---|---|
| gross profit margin | 98.12% |
| operating profit margin | -97.23% |
| pretax profit margin | -74.82% |
| net profit margin | -74.82% |
| return on assets | -13.56% |
| return on equity | -15.55% |
| return on capital employed | -18.64% |
liquidity ratios | |
|---|---|
| current ratio | 12.44 |
| quick ratio | 12.44 |
| cash ratio | 4.63 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 1,665.77 |
| cash conversion cycle | -1,665.77 |
| receivables turnover | 0.00 |
| payables turnover | 0.22 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -3.75 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.18 |
| cash per share | 8.78 |
| operating cash flow per share | -1.14 |
| free cash flow operating cash flow ratio | 1.03 |
| cash flow coverage ratios | -3.75 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -32.60 |
Frequently Asked Questions
When was the last time IDEAYA Biosciences, Inc. (NASDAQ:IDYA) reported earnings?
IDEAYA Biosciences, Inc. (IDYA) published its most recent earnings results on 04-11-2025.
What is IDEAYA Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)'s trailing twelve months ROE is -15.55%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. IDEAYA Biosciences, Inc. (IDYA) currently has a ROA of -13.56%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IDYA's net profit margin stand at?
IDYA reported a profit margin of -74.82% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IDYA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 12.44 in the most recent quarter. The quick ratio stood at 12.44, with a Debt/Eq ratio of 0.02.